MA18.05 Characteristics and Long-Term OS of Non-Small Cell Lung Cancer Patients Receiving EGFR Tyrosine Kinase Inhibitor Treatment

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.468 ◽

2018 ◽

Vol 13 (10) ◽

pp. S419

Author(s):

M. Bergqvist ◽

H. Nordahl Christensen ◽

F. Wiklund ◽

S. Bergström

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation

Lung Cancer ◽

10.1016/j.lungcan.2015.09.025 ◽

2015 ◽

Vol 90 (3) ◽

pp. 477-483 ◽

Author(s):

Tatsuya Yoshida ◽

Kiyotaka Yoh ◽

Seiji Niho ◽

Shigeki Umemura ◽

Shingo Matsumoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s143569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4261-4267 ◽

Author(s):

Ling Peng ◽

Yina Wang ◽

Yemin Tang ◽

Lei Zeng ◽

Junfang Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment

Journal of Nuclear Medicine ◽

10.2967/jnumed.114.140913 ◽

2014 ◽

Vol 55 (9) ◽

pp. 1417-1423 ◽

Author(s):

V. Frings ◽

M. Yaqub ◽

L. L. Hoyng ◽

S. S. V. Golla ◽

A. D. Windhorst ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Inhibitor Treatment

Download Full-text

Clinical Implications of High MET Gene Dosage in Non-Small Cell Lung Cancer Patients without Previous Tyrosine Kinase Inhibitor Treatment

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e92 ◽

2011 ◽

Vol 6 (12) ◽

pp. 2027-2035 ◽

Author(s):

Ya-Ting Chen ◽

John Wen-Cheng Chang ◽

Hui-Ping Liu ◽

Tsung-Fu Yu ◽

Yu-Ting Chiu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Gene Dosage ◽

Clinical Implications ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

10.1186/1471-2407-11-1 ◽

2011 ◽

Vol 11 (1) ◽

Author(s):

Satoshi Watanabe ◽

Junta Tanaka ◽

Takeshi Ota ◽

Rie Kondo ◽

Hiroshi Tanaka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

European Journal of Cancer ◽

10.1016/s0959-8049(11)72399-1 ◽

2011 ◽

Vol 47 ◽

pp. S618-S619

Author(s):

S. Watanabe ◽

Y. Saida ◽

K. Ichikawa ◽

J. Koshio ◽

J. Baba ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

PREDICTIVE FACTORS FOR LONG‐TERM RESPONDERS IN ADVANCED NON‐SMALL CELL LUNG CANCER PATIENTS TREATED WITH TYROSINE KINASE INHIBITOR

Respirology ◽

10.1111/resp.13700_281 ◽

2019 ◽

Vol 24 (S2) ◽

pp. 185-186

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Predictive Factors ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients

Lung Cancer ◽

10.1016/j.lungcan.2018.06.032 ◽

2018 ◽

Vol 123 ◽

pp. 60-69 ◽

Author(s):

Chong Hyun Suh ◽

Hye Sun Park ◽

Kyung Won Kim ◽

Junhee Pyo ◽

Hiroto Hatabu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504017x14928634401178 ◽

2017 ◽

Vol 25 (9) ◽

pp. 1601-1606 ◽

Author(s):

Baohong Yang ◽

Aiying Qin ◽

Kongyuan Zhang ◽

Haipeng Ren ◽

Shuzhen Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutant ◽

Inhibitor Treatment

Download Full-text

Proposal of new CT response criteria in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7035 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7035-7035

Author(s):

H. Lee ◽

K. Lee ◽

M. Ahn ◽

H. Hwang ◽

J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text